LEADER 01004nam0-2200289 --450 001 9910264660203321 005 20180410094512.0 010 $a88-8016-116-4 100 $a20180410d1995----kmuy0itay5050 ba 101 0 $aita 102 $aIT 105 $aa 001yy 200 1 $a<>statuti dei comuni e delle corporazioni in Italia nei secoli XIII-XVI$fBiblioteca del Senato della Repubblica$g[catalogo a cura di Sandro Bulgarelli] 210 $aRoma$cSenato della Repubblica$d1995 215 $a174 p.$cill.$d23 cm 300 $aMostra tenuta a Roma nel 1995-1996 610 0 $aStatuti$aItalia$aSec. 13.-16. 676 $a016.34845022$v19$zita 702 1$aBulgarelli,$bSandro 710 02$aItalia.$bSenato.$bBiblioteca$0423020 801 0$aIT$bUNINA$gREICAT$2UNIMARC 901 $aBK 912 $a9910264660203321 952 $aFONDO SENATO 75$b41/2018$fFSPBC 959 $aFSPBC 996 $aStatuti dei comuni e delle corporazioni in Italia nei secoli XIII-XVI$91504934 997 $aUNINA LEADER 05406nam 2200697 450 001 9910132337203321 005 20230803203258.0 010 $a1-118-58917-3 010 $a1-118-58919-X 010 $a1-118-58916-5 035 $a(CKB)3710000000134370 035 $a(EBL)1780034 035 $a(SSID)ssj0001261108 035 $a(PQKBManifestationID)11715811 035 $a(PQKBTitleCode)TC0001261108 035 $a(PQKBWorkID)11326988 035 $a(PQKB)10925068 035 $a(OCoLC)890441754 035 $a(MiAaPQ)EBC1780034 035 $a(DLC) 2014009510 035 $a(Au-PeEL)EBL1780034 035 $a(CaPaEBR)ebr10928099 035 $a(CaONFJC)MIL642303 035 $a(EXLCZ)993710000000134370 100 $a20140916h20142014 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt 182 $cc 183 $acr 200 00$aCancer consult $eexpertise for clinical practice /$fedited by Syed A. Abutalib, Maurie Markman 210 1$aHoboken, New Jersey :$cWiley-Blackwell,$d2014. 210 4$dİ2014 215 $a1 online resource (987 p.) 300 $aDescription based upon print version of record. 311 $a1-322-11052-2 311 $a1-118-58921-1 320 $aIncludes bibliographical references at the end of each chapters and index. 327 $aCover; Dedication; Title page; Copyright page; Contents; List of Contributors; Preface; SECTION 1: Malignant Hematology and Hematopoietic Cell Transplantation; PART 1: Acute Lymphoblastic Leukemia in Adults; CHAPTER 1: Diagnosis of acute lymphoblastic leukemia; Selected readings; Case study answers; CHAPTER 2: Prognostic markers and models in acute lymphoblastic leukemia; Pretherapeutic prognostic markers; Age; White blood cell count; Cytogenetic and genetic markers; Immunophenotype; Pro-B-ALL/t(4; 11); Common and pre-B-ALL; T-lineage ALL; Response parameters 327 $aStratification into risk groups Selected reading; CHAPTER 3: Management of B-cell acute lymphoblastic leukemia; Selected reading; CHAPTER 4: Management of T-cell acute lymphoblastic leukemia; Selected reading; CHAPTER 5: Minimal residual disease in acute lymphoblastic leukemia; Case study answers; Selected reading; CHAPTER 6: Hematopoietic cell transplantation in adult acute lymphoblastic leukemia; Multiple choice and discussion questions; Selected reading; Multiple choice answer; Case study answer; PART 2: Acute Myeloid Leukemia in Adults 327 $aCHAPTER 7: Prognosis in acute myeloid leukemia: cytogenetics and beyond Selected reading; Case study answers; CHAPTER 8: Induction therapy in acute myeloid leukemia; Selected reading; Case study answers; CHAPTER 9: Consolidation therapy in acute myeloid leukemia; Selected reading; CHAPTER 10: Management of acute promyelocytic leukemia; Selected reading; CHAPTER 11: Minimal residual disease in acute myeloid leukemia; Selected reading; CHAPTER 12: Relapsed and refractory acute myeloid leukemia; Multiple choice questions; Selected reading; Case study answers; Mutiple choise answers 327 $aCHAPTER 13: Hematopoietic cell transplantation in acute myeloid leukemia Multiple choice question; Case study answers; Multiple choice answer; Selected reading; PART 3: Myelodysplastic Syndromes and Related Disorders; CHAPTER 14: Pitfalls in the diagnosis of myelodysplastic syndromes; Selected reading; Case study answers; CHAPTER 15: Cytogenetics and prognostic models in myelodysplastic syndromes; MDS cytogenetics and prognosis; Conclusion; Selected reading; CHAPTER 16: Management of myelodysplastic syndromes; Selected reading; CHAPTER 17: Management of therapy-related myeloid neoplasms 327 $aIntroduction Multiple choice questions; What is the most appropriate treatment for the following patients?; Selected reading; Multiple choice answers; CHAPTER 18: Hematopoietic cell transplantation in myelodysplastic syndromes; Selected reading; CHAPTER 19: Acquired aplastic anemia; Selected reading; Case study answers; PART 4: Myeloproliferative Neoplasms; CHAPTER 20: Diagnostic approach in myeloproliferative neoplasms; Introduction; Selected reading; CHAPTER 21: Chronic myeloid leukemia: chronic phase; Introduction; Multiple choice and discussion questions; Selected reading 327 $aMultiple choice answer 330 $aThe field of oncology benefits from several large-scale reference books and a host of monographs dedicated to specific cancers. However, truly excellent practice and review books are, surprisingly, quite scarce. Outside of a scant handful of books and online reference tools that offer clinical response practice and board review in a basic question and answer format, there are no resources that offer a robust, engaging, fully referenced tool for these vital activities in every oncologist's and oncology trainee's work. This print and electronic book seeks to fill that void, offering comprehensive 606 $aCancer 606 $aStem cells$xTransplantation 606 $aOncology 615 0$aCancer. 615 0$aStem cells$xTransplantation. 615 0$aOncology. 676 $a616.99/40076 702 $aAbutalib$b Syed A. 702 $aMarkman$b Maurie 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910132337203321 996 $aCancer consult$92232067 997 $aUNINA LEADER 02238oam 2200469I 450 001 9910707866403321 005 20161213112045.0 035 $a(CKB)5470000002467893 035 $a(OCoLC)925444398 035 $a(EXLCZ)995470000002467893 100 $a20151015j199306 ua 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$a2D/3D Program work summary report /$fedited by P.S. Damerell, J. W. Simons 210 1$aWashington, DC :$cOffice of Nuclear Regulatory Research, U.S. Nuclear Regulatory Commission,$dJune 1993. 215 $a1 online resource (various pagings) $cillustrations 225 1 $aGRS ;$v100 225 1 $aInternational agreement report ;$v0126 300 $a"MPR-1345." 300 $a"Prepared jointly by Japan Atomic Energy Institute, Gesellschaft fuer Anlagen-und Reaktorsicherheit, Siemens AG, UB KWU, U.S. Nuclear Regulatory Commission, Los Alamos National Laboratory, MPR Associates, Inc." 300 $a"June 1993." 300 $a"Prepared as part of arrangement on Research Participation and Technical Exchange between the federal minister for research and technology of the Federal Republic of Germany (BMFT) and the Japan Atomic Energy Research Institute (JAERI) and the United States Nuclear Regulatory Commission (USNRC) in a coordinated analytical and experimental study of the thermo-hydraulic behavior of emergency core coolant during the refill and reflood phase of a loss-of-coolant accident in a pressurized water reactor (the 2D/3D Program)." 320 $aIncludes bibliographical references. 606 $aPressurized water reactors$xLoss of coolant 606 $aPressurized water reactors$xSafety measures 615 0$aPressurized water reactors$xLoss of coolant. 615 0$aPressurized water reactors$xSafety measures. 702 $aDamerell$b Paul S. 702 $aSimons$b J. W. 712 02$aU.S. Nuclear Regulatory Commission.$bOffice of Nuclear Regulatory Research, 801 0$bLLB 801 1$bLLB 801 2$bOCLCO 801 2$bOCLCQ 801 2$bGPO 906 $aBOOK 912 $a9910707866403321 996 $a2D$93265878 997 $aUNINA